KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rentokil Initial (RTO) EBITDA (2021 - 2024)

Historic EBITDA for Rentokil Initial (RTO) over the last 4 years, with Q4 2024 value amounting to $1.5 billion.

  • Rentokil Initial's EBITDA rose 10218.62% to $1.5 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $4.2 billion, marking a year-over-year change of. This contributed to the annual value of $451.8 million for FY2024, which is 13334.02% up from last year.
  • According to the latest figures from Q4 2024, Rentokil Initial's EBITDA is $1.5 billion, which was up 10218.62% from $747.2 million recorded in Q4 2023.
  • In the past 5 years, Rentokil Initial's EBITDA registered a high of $1.5 billion during Q4 2024, and its lowest value of $747.2 million during Q4 2023.
  • Moreover, its 4-year median value for EBITDA was $959.4 million (2021), whereas its average is $1.0 billion.
  • Per our database at Business Quant, Rentokil Initial's EBITDA plummeted by 2584.22% in 2023 and then soared by 10218.62% in 2024.
  • Over the past 4 years, Rentokil Initial's EBITDA (Quarter) stood at $911.3 million in 2021, then grew by 10.57% to $1.0 billion in 2022, then dropped by 25.84% to $747.2 million in 2023, then surged by 102.19% to $1.5 billion in 2024.
  • Its last three reported values are $1.5 billion in Q4 2024, $747.2 million for Q4 2023, and $1.0 billion during Q4 2022.